PT Kimia Farma Tbk (IDX:KAEF)
Indonesia · Delayed Price · Currency is IDR 490.00
+24.00 (5.15%)
Apr 15, 2026, 3:13 PM WIB
PT Kimia Farma Tbk Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9,223,328 | 9,938,958 | 9,871,842 | 9,232,676 | 12,857,627 | |
Revenue Growth (YoY) | -7.20% | 0.68% | 6.92% | -28.19% | 28.50% |
Cost of Revenue | 6,358,323 | 7,247,369 | 7,386,245 | 5,717,521 | 8,811,444 |
Gross Profit | 2,865,005 | 2,691,590 | 2,485,598 | 3,515,154 | 4,046,183 |
Selling, General & Admin | 2,567,280 | 2,967,740 | 3,681,094 | 2,889,203 | 2,860,390 |
Research & Development | 20,751 | 31,620 | 107,234 | 46,365 | 41,348 |
Other Operating Expenses | -82,655 | -55,439 | 55,091 | -134,094 | -39,660 |
Operating Expenses | 2,984,194 | 3,463,836 | 4,197,867 | 3,009,321 | 3,090,225 |
Operating Income | -119,189 | -772,246 | -1,712,269 | 505,834 | 955,958 |
Interest Expense | -586,324 | -640,832 | -597,149 | -525,608 | -606,813 |
Interest & Investment Income | 18,125 | 10,283 | 33,183 | 12,166 | 22,735 |
Currency Exchange Gain (Loss) | -2,323 | -1,966 | -2,044 | -1,138 | 6,637 |
Other Non Operating Income (Expenses) | 217,456 | 214,020 | - | - | - |
EBT Excluding Unusual Items | -472,255 | -1,190,740 | -2,278,280 | -8,747 | 378,517 |
Impairment of Goodwill | - | -53,877 | -26,889 | - | - |
Gain (Loss) on Sale of Investments | - | 15,153 | - | - | - |
Gain (Loss) on Sale of Assets | 5 | -7,643 | 2,022 | -13,603 | 2,112 |
Asset Writedown | -15,571 | 7,409 | 22,703 | 5,956 | 12,254 |
Other Unusual Items | 49,734 | - | - | - | - |
Pretax Income | -438,087 | -1,229,699 | -2,280,444 | -16,394 | 392,883 |
Income Tax Expense | 5,271 | -21,526 | -19,760 | 94,175 | 102,995 |
Earnings From Continuing Operations | -443,357 | -1,208,173 | -2,260,684 | -110,568 | 289,889 |
Earnings From Discontinued Operations | - | - | - | -15,456 | - |
Net Income to Company | -443,357 | -1,208,173 | -2,260,684 | -126,024 | 289,889 |
Minority Interest in Earnings | 108,398 | 365,900 | 296,528 | -64,448 | 12,385 |
Net Income | -334,959 | -842,272 | -1,964,157 | -190,473 | 302,274 |
Net Income to Common | -334,959 | -842,272 | -1,964,157 | -190,473 | 302,274 |
Net Income Growth | - | - | - | - | 1613.68% |
Shares Outstanding (Basic) | 5,567 | 5,567 | 5,562 | 5,561 | 5,554 |
Shares Outstanding (Diluted) | 5,567 | 5,567 | 5,562 | 5,561 | 5,554 |
Shares Change (YoY) | - | 0.08% | 0.01% | 0.13% | - |
EPS (Basic) | -60.17 | -151.31 | -353.14 | -34.25 | 54.42 |
EPS (Diluted) | -60.17 | -151.31 | -353.14 | -37.03 | 54.42 |
EPS Growth | - | - | - | - | 1613.68% |
Free Cash Flow | 102,078 | -48,103 | -1,113,887 | -499,985 | -874,686 |
Free Cash Flow Per Share | 18.34 | -8.64 | -200.27 | -89.91 | -157.49 |
Gross Margin | 31.06% | 27.08% | 25.18% | 38.07% | 31.47% |
Operating Margin | -1.29% | -7.77% | -17.34% | 5.48% | 7.43% |
Profit Margin | -3.63% | -8.47% | -19.90% | -2.06% | 2.35% |
Free Cash Flow Margin | 1.11% | -0.48% | -11.28% | -5.42% | -6.80% |
EBITDA | 219,579 | -407,971 | -1,182,970 | 867,821 | 1,300,090 |
EBITDA Margin | 2.38% | -4.11% | -11.98% | 9.40% | 10.11% |
D&A For EBITDA | 338,768 | 364,276 | 529,299 | 361,987 | 344,132 |
EBIT | -119,189 | -772,246 | -1,712,269 | 505,834 | 955,958 |
EBIT Margin | -1.29% | -7.77% | -17.34% | 5.48% | 7.43% |
Effective Tax Rate | - | - | - | - | 26.21% |
Advertising Expenses | 241,699 | 403,294 | 563,934 | 403,189 | 343,127 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.